Series B - New Haven Pharmaceuticals - Oct 23, 2014 Funding Round Profile - Cointime

Bitcoin $78,762.17 +2.92%
Ethereum $3,171.21 +4.24%
BNB $630.81 +0.21%
Optimism $1.66 +1.03%
Arbitrum $0.62 +2.59%
Solana $205.64 +2.36%
Polygon $0.40 +3.46%
Cosmos $4.95 +4.35%
Avalanche $31.45 +7.15%

Bitcoin $78,762.17 +2.92%
Ethereum $3,171.21 +4.24%
BNB $630.81 +0.21%
Optimism $1.66 +1.03%
Arbitrum $0.62 +2.59%
Solana $205.64 +2.36%
Polygon $0.40 +3.46%
Cosmos $4.95 +4.35%
Avalanche $31.45 +7.15%

New Haven Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 11.78M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail